Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect

Malignant forms of Mediterranean spotted fever: risk factors for fatal outcomes.

Splenic Rupture and Malignant Mediterranean Spotted Fever

6. Cooke RP, O’Neill WA, Xu J, Moore JE, Elborn JS. Inquilinus limosus isolated from a cystic fi brosis patient: fi rst UK report. Br J Biomed Sci. 2007;64:127–9. 7. Kiratisin P, Koomanachai P, Kowwigkai P, Pattanachaiwit S, Aswapokee N, Leelaporn A. Early-onset prosthetic valve endocarditis caused by Inquilinus sp. Diagn Microbiol Infect Dis. 2006;56:317–20. Epub 2006 Jul 18. 8. Rivarola V, Ca...

Erythromycin versus tetracycline for treatment of Mediterranean spotted fever.

Eighty one children aged between 1 and 13 years participated in a randomised comparative trial of tetracycline hydrochloride and erythromycin stearate for treatment of Mediterranean spotted fever. Both therapeutic regimens proved effective, but in patients treated with tetracycline both clinical symptoms and fever disappeared significantly more quickly. Likewise, when those patients who began t...

Ciprofloxacin therapy for Mediterranean spotted fever.

We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.

Mediterranean spotted fever in Algerian children.

Mediterranean spotted fever (MSF) is a potentially life-threatening zoonosis caused by Rickettsia conorii and transmitted by the brown dog tick Rhipicephalus sanguineus [1]. Although MSF is one of the oldest recognised rickettsioses, there have been few reports about this rickettsiosis in North Africa [1,2]. The present work on MSF cases occurring in children is a subset of a larger study condu...